Revance Therapeutics, Inc. — H1B Data for FY2022

Total LCAs (FY2022)
2
Certified
2
Denied
0
Average Salary
$137,500
Total Workers
2
PERM Certified
2

FY2022 H1B Overview for Revance Therapeutics, Inc.

In fiscal year 2022, Revance Therapeutics, Inc. filed 2 H1B labor condition applications with the U.S. Department of Labor. Of these, 2 were certified and 0 were denied. The average salary offered on these applications was $137,500.

The applications covered a total of 2 worker positions, as a single LCA can cover multiple workers in the same role and location.

Revance Therapeutics, Inc. also filed 4 PERM (green card) applications in FY2022, with 2 certified, indicating ongoing commitment to long-term sponsorship for foreign workers.

View Revance Therapeutics, Inc.'s complete sponsorship history on the full employer profile, including all years, job titles, and salary trends. Learn more about the H1B visa program in our comprehensive H1B visa guide.

FY2022 H1B Filings by Revance Therapeutics, Inc.

Individual labor condition applications filed by Revance Therapeutics, Inc. in fiscal year 2022. There are 2 filings total.

Case #StatusJob TitleSalaryLocationDate
I-200-22228-418310 Certified Associate Director, IT & R&D $175,000 – $200,000 Danville, CA 2022-08-23
I-200-22215-394347 Certified Production Support Engineer $100,000 – $110,000 Pflugerville, TX 2022-08-10

Revance Therapeutics, Inc. H1B History by Year

Browse Revance Therapeutics, Inc.'s H1B filing data for other fiscal years.

YearLCAsCertifiedDeniedAvg SalaryWorkers
FY2026 2 2 0 $122,526 2
FY2025 4 4 0 $135,525 4
FY2024 1 1 0 $162,000 1
FY2023 5 3 0 $150,186 5
FY2022 2 2 0 $137,500 2
FY2021 5 5 0 $136,285 5
FY2020 1 1 0 $120,931 1
FY2019 1 0 0 $115,000 1
FY2017 1 0 0 $125,000 1

Related Resources